Medical Weight Loss for Menifee, California Residents

Menifee, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Menifee through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Menifee patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for California residents. Doctor review just $119 (medication separate).

Why Menifee Residents Choose New Hope Weight Loss

New Hope was designed around the way Menifee residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

From our Costa Mesa, California practice, we provide Menifee with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

Telehealth is what lets us care for Menifee, California from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout Sun City, downtown, and the greater Riverside County area. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Menifee.

You can start this week from anywhere in California, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. The $119 fee covers the physician review and visit itself; the medication, whether semaglutide from $166 a month or tirzepatide from $233, is a separate charge. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Menifee patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Menifee

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Menifee address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Menifee

Can people from Menifee get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Menifee, California. Whether you are in Sun City, downtown, and the greater Riverside County area or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Menifee patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Menifee residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Menifee inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Menifee?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Menifee.

What areas of Menifee do you serve?

We serve patients from across Menifee by telehealth, including Sun City, downtown, and the greater Riverside County area.

What support is there for side effects for Menifee patients?

Dr. Sharma starts Menifee patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.

Menifee Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Menifee, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.